glp-1 vs metformin Ozempic for Weight Loss: Similarities and Differences Diabetes Drug Used For More

J Strength Cond Res Jul

Whether youre recovering from a torn ligament, managing arthritis, or experiencing wear-and-tear from sports, BPC-157 provides a science-backed alternative to surgery or lifelong medication

Members lose 54% more weight on average by combining our Points program with non-GLP-1 weight-loss medication versus taking meds alone.* *Based on a 12-week randomized controlled trial (n=101) that compared taking bupropion & naltrexone with the Weight Watchers behavioral program, including the Points Program

REDEFINE 2 Trial Type 2 Diabetes with Obesity The companion REDEFINE 2 trial, also published in 2025, enrolled 1,206 adults with type 2 diabetes and obesity or overweight, demonstrating the combinations efficacy in this more metabolically compromised population: Mean weight loss of 13.7% compared to 3.4% with placebo over 68 weeks 73.5% achieved hemoglobin A1c of 6.5% or less compared to 15.9% with placebo Greater proportions reaching multiple weight thresholds including 5%, 10%, 15%, and 20% reduction Significant glycemic improvement with mean A1c reduction demonstrating disease modification potential Favorable metabolic profile changes including improvements in blood pressure and lipids These findings established that the combination maintains substantial efficacy even in patients with the metabolic dysfunction of established type 2 diabetes, a population often showing reduced response to weight-loss interventions

It is not a drug, supplement, or food product

Macfabe D